Nxera Pharma Co Ltd (FRA:JSS)
€ 8.75 -0.3 (-3.31%) Market Cap: 793.19 Mil Enterprise Value: 946.53 Mil PE Ratio: 0 PB Ratio: 2.04 GF Score: 66/100

Sosei Group Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 09:30PM GMT
Release Date Price: €15.7 (+1.95%)
Daisuke Yoshizumi

Welcome to the 41st JPMorgan Annual Healthcare Conference. This is the APAC Lat Am track for the January 11, Wednesday. My name is Daisuke Yoshizumi, Global Healthcare Investment Banking team. I'm glad to introduce Chris Cargill, the President and CEO of the Sosei Group. So Chris?

Chris Cargill
Sosei Group Corporation - Representative Executive Officer, President, CEO & Director

Excellent. Thank you very much, Daisuke. Good afternoon, everyone. Thank you for those that have attended and a show of strength. I appreciate it. It's very nice to be back in San Francisco. My name is Chris Cargill, as Daisuke said. I'm the CEO of Sosei Group in Japan. All right, here in the room today, I am joined by our Chief Financial Officer, Hironoshin Nomura, over here on my right; and also Matt Barnes, who is the Head of our U.K. R&D operations.

I'll begin with a short overview of our history to orient people who aren't familiar with our business. Following that, I plan to talk to you about 4 key areas of focus for us over the next 3 to 5 years. We

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot